Pfizer Trovan Suspension Recommended In EU; Distribution Limited In U.S.
A 12-month suspension of Pfizer's Trovan has been recommended by the European Union's Committee for Proprietary Medicinal Products. Pfizer plans to appeal the decision.
A 12-month suspension of Pfizer's Trovan has been recommended by the European Union's Committee for Proprietary Medicinal Products. Pfizer plans to appeal the decision.